Ignite Creation Date:
2024-05-06 @ 4:10 PM
Last Modification Date:
2024-10-26 @ 2:05 PM
Study NCT ID:
NCT04890509
Status:
COMPLETED
Last Update Posted:
2021-10-14
First Post:
2021-05-17
Brief Title:
A Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients
Sponsor:
BerGenBio ASA
Organization:
BerGenBio ASA
Organization Data
Organization:
BerGenBio ASA
Class:
INDUSTRY
Study ID:
BGBC020
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BerGenBio ASA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None